Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > BIO2023 conference currently in Boston MA.
View:
Post by Noteable on Jun 07, 2023 10:15pm

BIO2023 conference currently in Boston MA.

Ends on June 8, 2023. Most everyone in biotech usually attends with many companies registered as exhibitors or partnering events. Lack of ONCY's presence suggests that the company's business development activities are being conducted away from the energy of this global "meet-up" and instead would seem to haven been formerly established during ASCO 2023 this past week.
Comment by fox7mf on Jun 08, 2023 9:28am
Good point. They no longer have to present data to sell, having just experienced center stage at ASCO. Bracelet is done, and it's resounding success, along with the success of IND and Aware just leave BD to concentrate on. 
Comment by Lesalpes29 on Jun 08, 2023 10:13am
Zero trust by investors actually! Waiting and manipulation continue!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities